Clinical Quality & Compliance Director

Heartflow is a medical technology company advancing the diagnosis and management of coronary artery disease, the #1 cause of death worldwide, using cutting-edge technology. The flagship product—an AI-driven, non-invasive cardiac test supported by the ACC/AHA Chest Pain Guidelines called the Heartflow FFRCT Analysis—provides a color-coded, 3D model of a patient’s coronary arteries indicating the impact blockages have on blood flow to the heart. Heartflow is the first AI-driven non-invasive integrated heart care solution across the CCTA pathway that helps clinicians identify stenoses in the coronary arteries (RoadMap™Analysis), assess coronary blood flow (FFRCT Analysis), and characterize and quantify coronary atherosclerosis (Plaque Analysis). Our pipeline of products is growing and so is our team; join us in helping to revolutionize precision heartcare.

Heartflow is a publicly traded company (HTFL) that has received international recognition for exceptional strides in healthcare innovation, is supported by medical societies around the world, cleared for use in the US, UK, Europe, Japan and Canada, and has been used for more than 750,000 patients worldwide.  

The Director, Clinical Quality & Compliance is responsible for the strategic oversight, management, and execution of clinical quality assurance and regulatory compliance programs across pre-market and post-market clinical research initiatives. The Director will work closely with internal Clinical Operations teams and cross-functional partners to support and monitor compliance, ensure adherence with FDA IDE requirements and Good Clinical Practice (GCP), and maintain inspection readiness across all studies, both  internally managed  and externally initiated or managed.

Job Responsibilities:

• Leads clinical quality and regulatory compliance strategies and initiatives across pre-market and post-market internal and external clinical programs.
• Ensures robust end-to-end clinical trial compliance with FDA Good Clinical Practice (GCP) guidelines (21 CFR Parts 50, 56, 312, 812) and ISO 14155.
• Oversees medical device labeling requirements, ensuring full compliance with FDA regulations and international labeling standards for post-market and investigational devices.
• Authors, reviews, and maintains Investigator’s Brochures (IB) for investigational medical devices being used in clinical research programs.
• Leads Bioresearch Monitoring (BIMO) audit preparation, internal GCP audits, vendor oversight, and external regulatory health authority inspections.
• Works closely with internal Clinical Operations and external CRO teams to ensure study protocols, execution strategies, and trial management practices align with regulatory and quality standards.
• Establishes clinical trial monitoring protocols and oversees key study deliverables, including Informed Consent Forms (ICFs), site monitoring oversight plans, and Trial Master File (TMF) quality standards.